The GLP-2 + Tirzepatide blend pairs two compounds that have attracted substantial interest in metabolic and gastrointestinal research. GLP-2 (Glucagon-Like Peptide-2) is an endogenous peptide produced in the intestinal tract that has been investigated for its role in gut mucosal maintenance, intestinal blood flow, and nutrient absorption processes. Tirzepatide is an investigational compound being studied in metabolic research models for its dual-agonist activity at GIP and GLP-1 receptors.

Research on GLP-2 has explored its trophic effects on intestinal epithelial tissue, particularly in models relevant to gut barrier integrity and bowel adaptation. Tirzepatide has been investigated in pre-clinical metabolic research models examining multi-receptor signaling pathways and their role in metabolic homeostasis. Combining these two compounds in a research preparation provides a tool for studying how GI and metabolic peptide axes may interact.

This blend is used in laboratory protocols where researchers want to study the combined effects of gut-targeted and metabolic peptide signaling in a single experimental framework. Both compounds represent distinct receptor targets, making this preparation relevant for multi-pathway metabolic research.

myPEPT supplies this research blend at ≥99% purity per component, with a Certificate of Analysis from third-party lab testing. Lyophilized and shipped across the EU for laboratory use.

What researchers should know: This is an investigational research blend and is not approved for human use. Neither component is intended for therapeutic application in this format. Handle in strict accordance with your institution's biosafety and compound handling protocols.